Curve Therapeutics

Curve Therapeutics has developed a powerful and dedicated medical discovery platform to identify a new generation of cancer drugs with significant clinical potential. Curve's core technology is derived from the School of Chemistry. Curve's platform is capable of discovering bioactive molecules to address challenges faced by traditional drug discovery technologies. Curve is utilizing this platform to build a pipeline of cancer drugs targeting disease-relevant but previously difficult-to-drug molecular targets. The company also aims to collaborate with pharmaceutical companies to identify new hits and leads for their priority disease targets.The core technology supporting Curve’s platform has been successfully used by Professor Tavassoli’s team to discover functional inhibitors of various protein-protein interactions. Some of these inhibitors have served as starting points for developing small-molecule leads with drug-like properties. They show considerable potential for clinical development and the treatment of various solid tumors.